Results 1 to 10 of about 506,753 (297)
Trial sequential analysis: novel approach for meta-analysis [PDF]
Systematic reviews and meta-analyses rank the highest in the evidence hierarchy. However, they still have the risk of spurious results because they include too few studies and participants.
Hyun Kang
doaj +4 more sources
Trial Sequential Analysis for dichotomous outcomes – a practical guide for systematic review protocols [PDF]
Background Trial Sequential Analysis (TSA) is a statistical method to control random errors in systematic reviews with meta-analyses of randomised clinical trials.
Sophie Juul +15 more
doaj +2 more sources
The adverse effects associated with semaglutide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis [PDF]
Background Semaglutide’s disease-specific weight-reducing effects are well established, but its adverse effects, which may not be disease-specific, have not been systematically assessed. The aim of this review was to assess the adverse effects associated
Christina Dam Bjerregaard Sillassen +15 more
doaj +2 more sources
No association between myeloperoxidase gene rs2333227 G>A polymorphism and Alzheimer's disease risk: a meta-analysis and trial sequential analysis [PDF]
Evidence suggests that there is a close association between myeloperoxidase (MPO) gene rs2333227 G>A polymorphism with Alzheimer’s disease (AD) susceptibility.
Zhi-Cheng Fang +4 more
doaj +1 more source
Background Adequately conducted systematic reviews with meta-analyses are considered the highest level of evidence and thus directly defines many clinical guidelines. However, the risks of type I and II errors in meta-analyses are substantial.
Christian Gunge Riberholt +3 more
doaj +1 more source
Background Assessing benefits and harms of health interventions is resource-intensive and often requires feasibility and pilot trials followed by adequately powered randomised clinical trials. Data from feasibility and pilot trials are used to inform the
Ravinder Claire +4 more
doaj +1 more source
Background: Remimazolam is a new ultrashort-acting benzodiazepine. Remimazolam has been approved for procedural sedation by the US Food and Drug Administration in 2020.
Bo-Jyun Jhuang +3 more
doaj +1 more source
BackgroundPatient's care bundle has been found to have a beneficial effect on refractory diseases, but the preventive effect of this strategy on stroke-associated pneumonia (SAP) remains unclear.
Feng Guo +3 more
doaj +1 more source
Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis
Background As a novel biomarker of inflammation, procalcitonin (PCT) has proven useful to guide antibiotic therapy in intensive care unit (ICU). However, there are controversial on mortality.
Tao Zhang +3 more
doaj +1 more source
Parallel Simulations for Analysing Portfolios of Catastrophic Event Risk [PDF]
At the heart of the analytical pipeline of a modern quantitative insurance/reinsurance company is a stochastic simulation technique for portfolio risk analysis and pricing process referred to as Aggregate Analysis.
Bahl, Aman +3 more
core +2 more sources

